Medical Oncologist
CION Cancer Clinics
A BRCA2 VUS: what an uncertain result really means | CION Cancer Clinics
A variant of uncertain significance in BRCA2 means the laboratory found a change in the gene and cannot yet say whether it raises cancer risk. It is not a positive result, and it should not change your treatment or lead to preventive surgery. This page explains why these results are common, how your care is planned instead, and what happens if the variant is reclassified later. At CION Cancer Clinics, our oncologists explain what a gene result means for you and your family, and plan the checks that follow.
NG
Medically reviewed by Dr. Naresh GunduConsultant Medical Oncologist · MBBS, DNB (Internal Medicine), DM (Medical Oncology, AIIMS) · last reviewed September 2026, next review due September 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
- What does a BRCA2 variant of uncertain significance mean?
- How is a VUS different from a positive or negative result?
- What happens after a VUS is reported?
- The words on a BRCA2 VUS report, in plain language
- A VUS compared with a harmful BRCA2 result
- What this page cannot tell you
- Four things families assume about a VUS
- Common questions about a BRCA2 VUS
The short answer
What does a BRCA2 variant of uncertain significance mean?
It means the laboratory found a change in your BRCA2 gene and cannot yet say whether it matters. It is not a positive result. Your care should be planned on your family history, exactly as if no change had been found.
Why BRCA2 throws up so many of these
BRCA2 is a very long gene, so there are many places where a small spelling difference can sit. Most of those differences are harmless and simply make one family different from another. To call one harmful, a laboratory needs evidence: other families with the same change, studies of how the protein behaves, or a pattern of cancer that follows the change through a family. For a rare change, that evidence often does not exist yet.
Why Indian families see more of them
Most of the world's reference data comes from people of European descent. A change that is common and harmless in Telangana may appear in almost no foreign database, so the laboratory has nothing to compare it against. That gap is closing slowly as more Indian results are shared.
Uncertain means unknown. It does not mean suspicious.Where a VUS sits
How is a VUS different from a positive or negative result?
Laboratories sort every change they find into one of five groups. A VUS is the middle one.
Pathogenic or likely pathogenic
The change is known, or very probably known, to break the gene. This is a positive result. It changes screening and can change treatment, and relatives can be tested for it.
Uncertain significance
The evidence points neither way. The change is reported so it is not lost, but it is not acted on.
It should not lead to
- Preventive surgery
- A change in cancer treatment
- Testing healthy relatives for the change
Likely benign or benign
The change is known, or very probably known, to be harmless. Many reports leave these out altogether because they carry no meaning for your health.
What happens over time
When a VUS is eventually reclassified, it far more often moves down to benign than up to harmful. That is the pattern laboratories report worldwide, and it is why a VUS is not treated as a warning.
Not sure whether this applies to you?
Ask an oncologistFrom report to reclassification
What happens after a VUS is reported?
-
Your counsellor explains the result
They confirm what the report says and, just as important, what it does not say. Your screening plan is set from your personal and family history.
-
The variant is logged and shared
Good laboratories submit the change, without your name, to shared databases such as ClinVar. Every family that reports the same change adds to the evidence.
-
Relatives with cancer may help
Sometimes the laboratory asks whether an affected relative will be tested. This is research into the variant, not a diagnosis for them, and it is always optional.
-
The evidence is reviewed again
Laboratories revisit uncertain variants as new studies appear. Some take a long time to settle, and a few never do.
-
You are told if it changes
A reclassification letter goes to the doctor who ordered the test. Keep your contact details with them current, and keep a copy of the report yourself.
On your report
The words on a BRCA2 VUS report, in plain language
- Variant
- A spelling difference in the gene. Everyone carries thousands of them across their genes.
- VUS
- Short for variant of uncertain significance. A change whose effect is not yet known.
- Missense
- A change that swaps one building block of the protein for another. Many VUS results are of this type, because a swap may or may not matter.
- Germline
- Present in every cell from birth, and so able to pass to children. This page is about germline results only.
- Reclassification
- A formal change to the label a variant carries, made when enough new evidence has built up.
- Segregation
- Whether a change travels with cancer through a family. It is one kind of evidence a laboratory uses to decide.
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
Side by side
A VUS compared with a harmful BRCA2 result
A harmful BRCA2 variant
A BRCA2 VUS
Screening follows the BRCA2 carrier plan
Screening follows your family history
Preventive surgery may be discussed
Preventive surgery is not offered on this basis
Some targeted medicines may become an option
Treatment is planned as usual
Healthy relatives can be tested for it
Healthy relatives are not tested for it
Being straight with you
What this page cannot tell you
It cannot tell you what your specific variant means. That is a question for the counsellor who ordered the test. Online databases and search results can show a variant with conflicting labels from different laboratories, and reading those alone causes real and needless fear.
Your family history still counts
A VUS does not cancel a strong family history. If several close relatives had breast, ovarian, prostate or pancreatic cancer, you may still need earlier or closer screening. That advice comes from the family tree, not from the variant.
Who this does not apply to
If your report found a harmful BRCA2 variant, this page is not for you. If the change was found only in a tumour sample, that is somatic testing, which belongs with targeted therapy and says nothing about what you inherited.
If you have a report in your hand and are unsure which kind it is, bring it to a counsellor before acting on anything.Commonly believed
Four things families assume about a VUS
"The test found something, so it must be bad."
The test found a difference. Almost everyone would show some difference if their whole BRCA2 gene were read. What matters is whether it breaks the gene, and for a VUS nobody knows that yet.
"I should have my breasts or ovaries removed to be safe."
Guidelines are clear that a VUS alone is not a reason for preventive surgery. Surgery decisions rest on a confirmed harmful variant or on a strong family history, discussed with a specialist.
"My sister should be tested for the same change."
Testing healthy relatives for a VUS gives answers no one can use. A negative result would falsely reassure and a positive one would falsely alarm. Relatives are guided by the family history instead.
"The answer will never change, so I can forget about it."
It may change. Keep the report, keep the ordering doctor's details, and ask every few years whether the classification has been reviewed.
Questions we are asked
Common questions about a BRCA2 VUS
Is a BRCA2 VUS a positive result?
No. A positive result means a change known to break the gene. A VUS means the laboratory does not yet know. Doctors plan your care as though the change had not been found, using your own history and your family's.
Can I still get PARP inhibitor treatment with a VUS?
A VUS on its own does not make someone eligible for medicines chosen because of a harmful BRCA variant. Your oncologist may still test the tumour itself, which is a separate question about the cancer. Ask them directly what applies to you.
How long until a VUS is reclassified?
Nobody can promise a timeline. Some are settled quickly because another family reports the same change. Others stay uncertain for many years. Rare changes seen mainly in Indian families can take longer, because there is less shared data to compare against.
Who will tell me if it changes?
Usually the laboratory writes to the doctor who ordered the test, who then contacts you. That chain breaks when phone numbers change. Keep your report, note the laboratory's name, and ask your counsellor how they track reclassifications.
Should I get a second laboratory to test it?
Repeating the test rarely helps, because the second laboratory will read the same spelling difference. What can differ is interpretation. Your counsellor can check whether other laboratories have classified the same change, which is often more useful than a new sample.
Do I need to mention a VUS for marriage or insurance?
A VUS is not a diagnosis and not a known risk, so it carries no medical meaning to disclose. India has no specific law protecting genetic results in insurance. Discuss what to share, and with whom, with your counsellor before you decide.
Can my children inherit a VUS?
Yes, it can pass to a child like any other variant. But since nobody knows whether it matters, testing children for it achieves nothing. BRCA2 testing in children is not advised in any case, because the risks it signals belong to adult life.
Where should I start if I have this report?
Book a post-test session with a genetic counsellor and take the report and a list of relatives with cancer. Ask what screening your family history alone calls for. Call the CION helpline if you are unsure who to see, and we will arrange it.
Your Specialists
Meet CION's oncologists. Bring your family history or genetic report to them.
Our medical oncologists see people with a strong family history of cancer, arrange genetic counselling and testing where it fits, and plan the checks that follow.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- National Cancer Institute — BRCA Gene Changes: Cancer Risk and Genetic Testing
- GeneReviews (NCBI) — BRCA1- and BRCA2-Associated Hereditary Breast and Ovarian Cancer
- ACMG (Genetics in Medicine) — Standards and guidelines for the interpretation of sequence variants
- MedlinePlus Genetics — BRCA2 gene
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
Why a VUS should not change treatmentThe reasoning behind treating a VUS as unknownHow variant reclassification worksWhat happens when the label on a variant changesIndian founder variants in BRCA2Why some BRCA2 changes are more common in Indian familiesSurveillance for BRCA2 carriersThe screening plan that applies when a harmful variant is found
Talk to us
Holding a BRCA2 report you do not understand?
Bring the report and a list of relatives who had cancer. A genetic counsellor will explain what it does and does not mean for you and your family. One helpline serves every CION centre.